A study led by Giorgia Sulis, a postdoctoral fellow in the Department of Epidemiology, Biostatistics and Occupational Health, was cited by the Economist.
Researchers at Ï㽶ÊÓƵ have discovered bacterial organelles involved in gene expression, suggesting that bacteria may not be as simple as once thought. This finding could offer new targets for the development of new antibiotics.
The study, published in , is the first to show that E. coli uses similar strategies to regulate gene transcription as other more complex cell types.
Insight into way enzymes work could shape future therapeutic production
Ìý
Researchers at Ï㽶ÊÓƵ’s Faculty of Medicine have made important strides in understanding the functioning of enzymes that play an integral role in the production of antibiotics and other therapeutics. Their findings are published in Science.
Antibiotic resistance is a growing global health threat. So much so that a 2014 study commissioned by the Prime Minister of the United Kingdom predicted that, if the problem is left unchecked, in less than 35 years more people will die from antibiotic resistant superbugs than from cancer. It is critical that researchers develop new antibiotics informed by knowledge of how superbugs are resistant to this medication.
McGill Newsroom
As a result of the overuse or misuse of antibiotics, antimicrobial resistant superbugs represent an extraordinary threat to global health. This threat is particularly great in India, the world’s largest consumer of antibiotics and the country facing the highest burden of tuberculosis (TB) in the world.
Antibiotic resistance represents a major challenge in treating pathogenic bacterial infections.
Now, researchers at Ï㽶ÊÓƵ have discovered a possible target for fighting back against resistant bacteria.
A concentrated extract of maple syrup makes disease-causing bacteria more susceptible to antibiotics, according to laboratory experiments by researchers at Ï㽶ÊÓƵ.